U.S. markets open in 3 hours 46 minutes
  • S&P Futures

    4,224.25
    +14.25 (+0.34%)
     
  • Dow Futures

    33,389.00
    +129.00 (+0.39%)
     
  • Nasdaq Futures

    13,435.25
    +43.25 (+0.32%)
     
  • Russell 2000 Futures

    1,977.70
    +8.20 (+0.42%)
     
  • Crude Oil

    92.74
    +0.81 (+0.88%)
     
  • Gold

    1,805.20
    -8.50 (-0.47%)
     
  • Silver

    20.47
    -0.27 (-1.31%)
     
  • EUR/USD

    1.0330
    +0.0028 (+0.27%)
     
  • 10-Yr Bond

    2.7860
    0.0000 (0.00%)
     
  • Vix

    20.00
    -1.77 (-8.13%)
     
  • GBP/USD

    1.2213
    -0.0005 (-0.04%)
     
  • USD/JPY

    132.6600
    -0.2130 (-0.16%)
     
  • BTC-USD

    24,501.94
    +1,450.56 (+6.29%)
     
  • CMC Crypto 200

    577.32
    +46.10 (+8.68%)
     
  • FTSE 100

    7,489.06
    -18.05 (-0.24%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Best Healthcare Dividend Stock Picks

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Generally, companies in the healthcare sector such as Kewaunee Scientific often provide attractive dividend yields due to relatively stable earnings as these are considered defensive sectors that can make money in any economic environment. Therefore, these companies provide a strong reliable stream of constant income which is a great diversifier during economic downturns. I’ve identify the following healthcare stocks paying high income, which may increase the value of your portfolio.

Kewaunee Scientific Corporation (NASDAQ:KEQU)

KEQU has a decent dividend yield of 2.30% and their current payout ratio is 33.79% . In the case of KEQU, they have increased their dividend per share from US$0.28 to US$0.68 so in the past 10 years. The company has been a dependable payer too, not missing a payment in this 10 year period. Kewaunee Scientific’s performance over the last 12 months beat the us medical equipment industry, with the company reporting 15.21% EPS growth compared to its industry’s figure of 11.06%. More on Kewaunee Scientific here.

NasdaqGM:KEQU Historical Dividend Yield Mar 9th 18
NasdaqGM:KEQU Historical Dividend Yield Mar 9th 18

Aceto Corporation (NASDAQ:ACET)

ACET has a sizeable dividend yield of 3.52% and a reasonably sustainable dividend payout ratio , with analysts expecting this ratio to be 19.92% in the next three years. ACET’s last dividend payment was US$0.26, up from it’s payment 10 years ago of US$0.20. They have been consistent too, not missing a payment during this 10 year period. During the previous five year period, the company has maintained a positive earnings growth. Although it has not been exceptional growth, investors should take confidence in the fact that the company has not experienced significant earnings growth downturn. Interested in Aceto? Find out more here.

NasdaqGS:ACET Historical Dividend Yield Mar 9th 18
NasdaqGS:ACET Historical Dividend Yield Mar 9th 18

National HealthCare Corporation (AMEX:NHC)

NHC has a good dividend yield of 3.11% and their current payout ratio is 51.08% . The company’s dividends per share have risen from US$0.84 to US$1.92 over the last 10 years. Much to the delight of shareholders, the company has not missed a payment during this time. National HealthCare’s performance over the last 12 months beat the us healthcare industry, with the company reporting 11.21% EPS growth compared to its industry’s figure of 8.84%. Dig deeper into National HealthCare here.

AMEX:NHC Historical Dividend Yield Mar 9th 18
AMEX:NHC Historical Dividend Yield Mar 9th 18

For more solid dividend paying companies to add to your portfolio, explore this interactive list of top dividend payers. Or create your own list by filtering companies based on fundamentals such as intrinsic discount, health score and future outlook using this free stock screener.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.